bioRxiv Science⌕ Search

Biology subjects

Ganapathy, S.

Publications and source records attributed to Ganapathy, S..

5 recordsLinked to original sources

Library docking for Cannabinoid-2 Receptor ligands

Cannabinoid receptors are therapeutically promising GPCRs that are also interesting test systems for structure-based methods, which have targeted them previously. Here we used the CB2 receptor as a template to explore several topical questions in library docking. Whereas an earlier campaign against the CB1 receptor led to potent but relatively non-selective ligands, here we found that targeting interactions with polar, orthosteric site residues led to subtype-selective ligands. Docking hit rate and especially hit affinity improved in moving from a 7 million to a 2.6 billion molecule library. Similar to earlier studies, docking against active and inactive states of the receptor did not reliably bias toward the discovery of agonists or inverse agonists. Cryo-EM structures of two of the new agonists, each in a different chemotype, superposed well on the docking predictions. Correspondingly, structure-based optimization led to 10- to 140-fold improvements within three different series, also consistent with well-behaved ligand families. Hit rates with a fully enumerated 2.6 billion molecule library resembled those of an implied 11 billion molecule library from a building-block method, consistent with the latters ability to explore this space, though higher affinities were discovered from the fully enumerated set. Overall, eight diverse families of ligands, with potencies <100 nM and mostly unrelated to previously known ligands were found. Implications for future studies are considered.

biochemistry↗

Exploring Bioelectricity with Ace2N-mNeon during Zebrafish Embryogenesis

Bioelectricity is a fundamental biophysical phenomenon present in all cells, playing a crucial role in embryogenesis by regulating processes such as neuronal signaling, pattern formation, and cancer suppression. Precise monitoring of bioelectric signals and their dynamic changes throughout development is vital for advancing our understanding of higher organisms. However, the lack of suitable techniques for mapping bioelectric signals during early development has greatly limited our ability to interpret these mechanisms. To address this challenge, we developed an Ace2N-mNeon expression library in zebrafish, which exhibits membrane localization from 4 hours post-fertilization to at least 5 days post- fertilization and broad expression across multiple cell types throughout development. We validated the use of this library for studying bioelectric changes via voltage imaging to record signals in neurons and cardiomyocytes at different development stages. Through this approach, we found evidence of synchronized neuronal activity during early embryogenesis and observed faster voltage dynamics in cardiomyocytes as development progressed. Our results show that the Ace2N-mNeon library is a valuable tool for developmental bioelectric studies supporting advanced techniques such as voltage imaging and fluorescence lifetime imaging (FLIM). These methods enable non-invasive, dynamic monitoring of bioelectric signals across diverse cell types throughout development, significantly surpassing the capabilities of current electrophysiological techniques.

developmental biology↗

In Vivo Plasmonic Enhancement of the Photocycle Dynamics and Fluorescence of Genetically Encoded Voltage Indicators

Plasmonic nanoparticles are key components in nanophotonics1-11 and have applications in molecular detection and diagnostic platforms. 12-14 Coupling of dipoles to plasmonic antennas has allowed engineering of qualitatively altered behavior in isolated quantum systems, 8,15 but this promise has not been fulfilled in living systems, where the use of plasmonics is limited to tissue level applications of plasmonic particles as contrast agents16 or heat sources.17 Here we show that coupling to designed plasmonic nanoparticles can control the electrophysiological function of proteins in living cells. We designed nanostar geometries and achieved robust near-field coupling of these optimized nanoparticles to plasma membrane-localized Archaerhodopsin proteins. We enhanced the fluorescence of the coupled rhodopsins and increased their response speed to membrane voltage. We incorporated this plasmonic enhancement into a Markov chain photocycle model of the Archaerhodopsin mutant QuasAr6a, showing an increased fluorescence emission rate and manipulation of the protein dynamics through a combination of photocycle transition rate enhancements. These results represent the first scalable near-field coupling between plasmonic particles and fluorescent proteins in living cells. They show enhancement of protein function beyond what has been achievable through genetic engineering. This opens up a range of possibilities for engineering biological functionality through plasmonics.

biophysics↗

Expanding the family of genetically encoded voltage indicators: Insights from heliorhodopsins

Genetically encoded voltage indicators (GEVIs), particularly those based on microbial rhodopsins, are gaining traction in neuroscience as fluorescent sensors for imaging voltage dynamics with high-spatiotemporal precision. Here we establish a novel GEVI candidate based on the recently discovered subfamily of the microbial rhodopsin clade, termed heliorhodopsins. We discovered that upon excitation at 530-560nm, wild type heliorhodopsin exhibits near infra-red fluorescence which is sensitive to membrane voltage. We characterized the fluorescence brightness, photostability, voltage sensitivity and kinetics of wild type heliorhodopsin in HEK293T cells and further examined the impact of mutating key residues near the retinal chromophore. The S237A mutation significantly improved the fluorescence response of heliorhodopsin by 76% providing a highly promising starting point for further protein evolution.

biophysics↗

Structure-based discovery of cannabinoid-1 receptor agonists with reduced side effects

Large library docking can reveal unexpected chemotypes that complement the structures of biological targets. Seeking new agonists for the cannabinoid-1 receptor (CB1R), we docked 74 million tangible molecules, prioritizing 46 high ranking ones for de novo synthesis and testing. Nine were active by radioligand competition, a 20% hit-rate. Structure-based optimization of one of the most potent of these (Ki = 0.7 {micro}M) led to 4042, a 1.9 nM ligand and a full CB1R agonist. A cryo-EM structure of the purified enantiomer of 4042 ( 1350) in complex with CB1R-Gi1 confirmed its docked pose. The new agonist was strongly analgesic, with generally a 5-10-fold therapeutic window over sedation and catalepsy and no observable conditioned place preference. These findings suggest that new cannabinoid chemotypes may disentangle characteristic cannabinoid side-effects from their analgesia, supporting the further development of cannabinoids as pain therapeutics.

pharmacology and toxicology↗